LANGLARA

Product NDC
87682-090
Requested package NDC
87682-090-05
11-digit product format
876820090
Labeler code
87682
Product ID
87682-090_5dececb8-5164-dca7-e063-6394a90ae2b8
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
insulin glargine-aldy
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Labeler
Lanexa Biologics, LLC
Application
BLA761412
Marketing category
BLA
Marketing start
2026-07-01
Substance
INSULIN GLARGINE
Active strength
100 [iU]/mL
Pharmacologic classes
Insulin Analog [EPC], Insulin [CS]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
LANGLARA
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
INSULIN GLARGINE100 [iU]/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
2ZM8CX04RZInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
2746568Internal RxNorm lookup
2746571Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
5328761e-59d3-ca7a-e063-6394a90ae810Available on FDA.report

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761412Langlarainsulin glargine-aldy351(k) InterchangeableRx2026-10-01

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
87682-090-05876820090055 SYRINGE in 1 CARTON (87682-090-05) / 3 mL in 1 SYRINGE (87682-090-01) 5 syringe2026-07-01NoNoCurrent